1. Iigo M, Sakurai M, Shimizu M,et al. 1986, Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-β.Proc Jpn Acad,62 (ser. B), 275–8.
2. Brunda MJ, Bellantoni B and Sulich V, 1987,In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.Int J Cancer,40, 365–71.
3. Iigo M, Sakurai M, Tamura T, Saijo N and Hoshi A, 1988,In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.Cancer Res,48, 260–4.
4. Cameron RB, McIntosh JK and Rosenberg SA, 1988, Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid α-interferon in the treatment of established murine hepatic metastases.Cancer Res,48, 5810–17.
5. Rosenberg SA, Schwarz SL and Spiess PJ, 1988, Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes.JNCI,80, 1393–7.